![Kent Öbrink](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kent Öbrink
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kent Öbrink
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Electronic Equipment/Instruments | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kent Öbrink
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
XRF Analytical AB
![]() XRF Analytical AB Packaged SoftwareTechnology Services XRF Analytical AB specializes in the development of software for quantification and analysis of digital measurements from wave length dispersive x-ray fluorescence spectrometers. The company was founded in 2002 and is headquartered in Orsundsbro, Sweden. | Packaged Software | Chairman | |
C-RAD AB | Medical Specialties | Founder | |
Provell Pharmaceuticals LLC
![]() Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member | |
ELEKTA AB | Medical Specialties | Corporate Officer/Principal | |
RAYSEARCH LABORATORIES AB | Packaged Software | Founder | |
RECIPHARM AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer | |
RayIncentive AB | Investment Managers | Chairman | |
Eurona Medical Ab
![]() Eurona Medical Ab Hospital/Nursing ManagementHealth Services Part of Gemini Holdings Plc, Eurona Medical Ab operates a medical facility. The CEO of the Swedish company is Eugen Steiner. Eurona Medical was acquired by Gemini Holdings Plc on December 20, 1999 for $5.04 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
University of Uppsala | College/University | Graduate Degree Undergraduate Degree | |
NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
University of Stockholm | College/University | Graduate Degree | |
Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
ALPHAHELIX MOLECULAR DIAGNOSTICS AB | Medical Distributors | Corporate Officer/Principal | |
C-RAD Positioning AB | Chairman | ||
C-RAD Imaging AB | Chairman | ||
C-RAD Innovation AB | Chairman | ||
Moleculink AB
![]() Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Biotechnology | Chief Executive Officer | |
Recipharm Strängnäs AB
![]() Recipharm Strängnäs AB Miscellaneous Commercial ServicesCommercial Services Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry. | Miscellaneous Commercial Services | Director/Board Member | |
Pygargus AB
![]() Pygargus AB Miscellaneous Commercial ServicesCommercial Services Part of IQVIA, Inc., Pygargus AB is a Swedish company that provides market research and consulting services for the pharmaceutical sector. The company is based in Stockholm, Sweden. The company was founded by Ragnar Linder. Pygargus was acquired by IQVIA, Inc. from Ängshöken AB on December 09, 2013. | Miscellaneous Commercial Services | Founder | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Umecrine Cognition AB
![]() Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Scandiflash AB
![]() Scandiflash AB Medical SpecialtiesHealth Technology Scandiflash AB is a Swedish company that manufactures and sells X-ray systems. The private company is based in Uppsala, Sweden. | Medical Specialties | Chairman | |
Scandiflash Holding AB | Chairman | ||
hhDesign AB | Chairman | ||
EDX Diagnostics SpA | Founder | ||
ENVIROLOGIC AB | Industrial Machinery | Chairman | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Cormorant Pharmaceuticals AB
![]() Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Corporate Officer/Principal | |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member | |
Flerie Invest AB
![]() Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor | |
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member | |
Recipharm (Venture Capital) | Investment Managers | Chief Executive Officer | |
Atrogi AB
![]() Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
LIPUM AB | Biotechnology | Director/Board Member | |
Beamocular AB | Director/Board Member | ||
RPH Pharmaceuticals AB
![]() RPH Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, RPH Pharmaceuticals AB is a Swedish company that manufactures pharmaceutical products. The company is based in Jordbro, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Nolsterby Invest AB
![]() Nolsterby Invest AB Investment Banks/BrokersFinance Nolsterby Invest AB is a Swedish company that provides securities trading and management services. The private company is based in Uppsala, Sweden. The CEO of the company is Anders Hedlund. | Investment Banks/Brokers | Chairman | |
ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
Recipharm OT Chemistry AB
![]() Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Chairman | |
R Linder Holding AB | Director/Board Member | ||
Binx Health Ltd.
![]() Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Bostadsrättsföreningen Smultronhyllan | Chairman | ||
Prokarium Holdings Ltd.
![]() Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member | |
EpiEndo Pharmaceuticals ehf
![]() EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Buzzard Pharmaceuticals AB
![]() Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member | |
3D Trace AB | Director/Board Member | ||
Tegnér Biotech Consulting AB | Director/Board Member |
Statistik
International
Schweden | 44 |
Italien | 3 |
Vereinigtes Königreich | 3 |
Niederlande | 2 |
Vereinigte Staaten | 2 |
Sektoral
Health Technology | 21 |
Finance | 5 |
Commercial Services | 5 |
Consumer Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 37 |
Chairman | 19 |
Chief Executive Officer | 11 |
Corporate Officer/Principal | 11 |
Independent Dir/Board Member | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kent Öbrink
- Unternehmensverbindungen